Related Experiment Video
Updated: Aug 30, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Effect of N-terminal and Met23 mutations on the structure and dynamics of onconase
Vitaliy Y Gorbatyuk1, Cheng-Kun Tsai, Chi-Fon Chang
1Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 11529, Taiwan, Republic of China.
Abstract:
Onconase (rONC), otherwise known as ranpirnase or P-30 protein, which was initially purified from extracts of Rana pipiens oocytes and early embryos, exhibits anticancer activity both in vitro and in vivo and is in phase III clinical trials for tumor therapy. We have determined the solution NMR structure of a recombinant onconase with Met(-1), Gln1, and Leu23 residues (M-1, Q1, M23L)rONC. The 20 best solution structures had a backbone root mean square deviation of 0.41 +/- 0.09 A with respect to the average structure. The energy-minimized average NMR structure had a backbone root mean square deviation of 0.72 A from the x-ray crystallographic structure of native onconase; however, the orientation of the N-terminal residue in the two structures was very different. Comparison of the 15N HSQC spectrum of (M-1, Q1, M23L)rONC with that of a mutant E1S-rONC, which is identical to the nONC except with the N-terminal pyroglutamyl residue replaced by Ser, showed that N-terminal and residue 23 mutations induced structural changes in regions beyond the mutation sites. Model-free analysis of the backbone amide 15N-T1, 15N-T2, and 15N-1H NOE relaxation data for (M-1, Q1, M23L)rONC and E1S-rONC revealed that the E1S-rONC molecule showed very little flexibility, whereas (M-1, Q1, M23L)rONC exhibited substantial flexibility, which may account for the previously observed reduced stability and increased protease susceptibility. The alpha1 helix and beta-sheets of (M-1, Q1, M23L)rONC displayed bending motions. These data provided strong evidence for the presence of an N-terminal hydrogen bond network in E1S-rONC, but not in (M-1, Q1, M23L)rONC.
Insights
Recombinant onconase (rONC) exhibits flexibility and structural changes due to mutations, impacting its stability and anticancer potential. These findings offer insights into ranpirnase
Area of Science:
- Biochemistry
- Structural Biology
- Biophysics
Background:
- Onconase (rONC), a protein with anticancer activity, is undergoing clinical trials for tumor therapy.
- Understanding the structural dynamics of recombinant onconase is crucial for optimizing its therapeutic efficacy.
Purpose of the Study:
- To determine the solution NMR structure of recombinant onconase (M-1, Q1, M23L)rONC.
- To investigate the structural and dynamic differences between wild-type and mutant onconase variants.
Main Methods:
- Solution Nuclear Magnetic Resonance (NMR) spectroscopy was employed to determine the structure of (M-1, Q1, M23L)rONC.
- 15N HSQC spectra and model-free analysis of relaxation data (15N-T1, 15N-T2, 15N-1H NOE) were used to assess molecular dynamics.
Main Results:
- The NMR structure of (M-1, Q1, M23L)rONC was determined, revealing distinct N-terminal residue orientation compared to the x-ray structure.
- Mutations in onconase induced structural changes and significantly increased flexibility in (M-1, Q1, M23L)rONC compared to E1S-rONC.
- The alpha1 helix and beta-sheets of (M-1, Q1, M23L)rONC exhibited bending motions, and a key N-terminal hydrogen bond network was absent.
Conclusions:
- The increased flexibility and altered structural dynamics of (M-1, Q1, M23L)rONC may explain its reduced stability and increased susceptibility to proteases.
- The findings highlight the impact of specific mutations on onconase structure and dynamics, providing a basis for further therapeutic development.
Related Concept Videos
Mutations
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cooperative Allosteric Transitions
ATP Synthase: Mechanism
